Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Lars Rebien Sørensen
Age : 66
Public asset : 4,901,873 USD
Country of residence : Unknown
Linked companies : Thermo Fisher Scientific Inc. - Essity AB (publ)

Biography of Lars Rebien Sørensen 
Mr. Lars Rebien Sørensen is a Chairman at Novo Holdings A/S, a Chairman at Novo Holdings A/S, an Independent Director at Essity AB, an Independent Director at Thermo Fisher Scientific, Inc. and a Chairman at Novo Nordisk Fonden. He is on the Board of Directors at Essity AB, Thermo Fisher Scientific, Inc. and Jungbunzlauer AG. He has over 34 years of general management experience in the pharmaceutical industry. He joined the Novozymes A/S (then Novo Nordisk A/S, Enzymes Division) marketing team in 1982. Over the years he held various global positions across the Middle East and the United States. In 1994, he was appointed a member of the corporate management team and assumed responsibility for the Novozymes A/S healthcare business. In November 2000 he became President and CEO of Novo Nordisk A/S, a position he held until December 2016. He received an MSc in Forestry from the Copenhagen Royal Veterinary and Agricultural University in 1981 and a BSc in International Economics from Copenhagen Business School in 1983.


Current positions of Lars Rebien Sørensen 
Holdings of Lars Rebien Sørensen 
Lars Rebien Sørensen : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/01RICHARD BRANSON : U.S. aviation agency probes Branson's Virgin Galactic flight deviation
RE
More news


© 2021 People and Ownership :   
Lars Rebien Sørensen : Connections 


Latest news about Lars Rebien Sørensen 
2018Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid
RE
2017NOVO NORDISK A/S : Free rent, iconic sites offered in race for London's EU agencies
RE
2017SCA Approves Dividend for the Year 2016, Payable on April 12, 2017; Approves Appointment of Lars Rebien Sörensen as Director
CI
2017NOVO NORDISK A/S : replaces head of North American operations
RE
2017Denmark joins race to host EU drug agency instead of London after Brexit
RE
2016Denmark's DSV eyes more big acquisitions in fragmented freight market
RE
2016Novo Nordisk to ax 1,000 jobs in cost-cutting drive
RE
More news